Breast implant illness (BII) describes a cluster of systemic symptoms — fatigue, joint and muscle pain, brain fog, and many others — that some women attribute to their implants. It’s worth being clear about both halves of the picture: BII is not an established medical diagnosis. But that doesn’t mean the symptoms aren’t real, and it doesn’t mean there’s nothing to it. Implants do shed compounds into the body over time, and — much like microplastics — that adds a burden the body has to manage. Most people seem to cope; some don’t. And notably, most women who have their implants removed report that their symptoms improve.
The honest starting point
This topic is polarised, which doesn’t help the women living with it. On one side, symptoms get dismissed as imagined or unrelated. On the other, implants get blamed with a certainty the evidence doesn’t support. Neither is accurate, and neither is useful.
Here’s the balanced version. BII remains an unofficial diagnosis — there’s no lab test or scan that confirms it, and no definitive causal link has been established between implants and systemic disease¹ ². At the same time, the symptoms are real, consistent enough across thousands of women to have been catalogued (over 50 distinct symptoms), and increasingly studied seriously rather than dismissed¹ ³.
The microplastics comparison
A helpful way to think about implants is the way we’ve come to think about microplastics.
We now know microplastics are present in nearly everyone’s body. That doesn’t mean everyone with microplastics is sick — most people aren’t obviously affected. But few would argue that a foreign material accumulating in human tissue is a good thing, and it’s reasonable to see it as a burden the body has to deal with, one that may matter more for some people than others.
Implants fit the same logic. They introduce a foreign material that doesn’t stay perfectly sealed and inert. Whether that becomes a problem depends on the person. This is the key idea, and it runs through much of how the body handles anything: an exposure isn’t automatically harmful or harmless — it depends on the dose, the individual’s capacity to deal with it, and everything else they’re already carrying.
Implants do shed compounds — this part is documented
One thing that isn’t in dispute: implants aren’t sealed vaults. They release material into the surrounding tissue even when intact.
This happens through “gel bleed” — the slow diffusion of silicone through an intact implant shell — a phenomenon accepted in the medical literature⁴. Over time, silicone can migrate beyond the implant. Silicone has been documented in the lymph nodes of women with implants, and in one study, evidence of silicone in the lymph nodes was found in the large majority of implant patients — with only about half of those implants showing any visible rupture⁵. In other words, migration doesn’t require the implant to break.
Newer highly cohesive gels reduced this considerably compared with older implants, but didn’t eliminate it⁶. So the claim that implants introduce foreign material into the body, gradually, without needing to rupture, is well supported. What that material does once it’s there is the part that’s less settled.
Why some women react and others don’t
If implants shed compounds into everyone with them, why do only some women develop symptoms? The same reason only some people seem affected by any given exposure: individual variation.
People differ in how well they clear foreign compounds, in how reactive their immune system is, and in how much other burden they’re already carrying — other exposures, stress, gut health, nutrient status, genetics. For someone with plenty of spare capacity, an added burden may never surface as symptoms. For someone already close to their limit, the same burden may be what tips them over.
This is why BII is so hard to pin down, and why blanket statements in either direction fail. It isn’t “implants harm everyone” or “implants harm no one.” It’s that the same exposure lands differently on different people — which is really difficult to study, but matches how the rest of the body works.
The strongest evidence: what happens after removal
If you want the single most useful fact in this whole area, it’s this.
Across multiple systematic reviews covering large numbers of women, the substantial majority who have their implants removed report that their symptoms improve. One 2024 review found symptom improvement in around 83.5% of patients where this was reported; a 2025 meta-analysis found around 81.9% reported improvement, with symptoms reduced by roughly half on average⁷ ⁸.
It’s a striking and consistent pattern across tens of thousands of women, and it’s the strongest signal available that, for many, the implants were contributing to how they felt. It’s also far more informative than any list of chemicals.
What symptoms are we talking about?
BII symptoms are systemic — they’re rarely confined to the breast. The most consistently reported, drawn from reviews of over 10,000 patients, include⁹:
- Fatigue and general malaise
- Joint and muscle pain
- Cognitive difficulties — “brain fog,” memory and concentration problems
- Muscle weakness
- Widespread or undefined pain
Because these overlap heavily with many common conditions — thyroid problems, autoimmune disease, chronic fatigue, perimenopause, and others — it’s also important that other causes are investigated properly rather than everything being attributed to implants. That works in both directions: it protects women from having a treatable condition missed, and from assuming implants are blameless when they may be contributing.
Proposed mechanisms — how this is thought to work
Researchers and clinicians have proposed several ways implants might contribute to symptoms in susceptible people:
- Immune activation. The body treats the implant and any shed material as foreign, mounting a low-grade immune and inflammatory response. Some frame this within a proposed condition called ASIA (autoimmune/inflammatory syndrome induced by adjuvants), though ASIA itself remains debated¹.
- Added detoxification burden. The compounds released require processing and clearance by the body’s normal detoxification pathways. The idea is that in someone whose capacity is already stretched, this added load competes with other functions.
- A foreign body reaction to migrated silicone in tissues such as lymph nodes, which is documented, even if its link to the wider symptom picture isn’t fully established⁵.
These are plausible and worth researching. What they offer is a reasonable account of why a foreign material might affect some people and not others — consistent with the variation seen in practice.
The one clearly established risk: BIA-ALCL
Separate from BII, and much better established, is a specific cancer link worth knowing about.
BIA-ALCL (breast implant-associated anaplastic large cell lymphoma) is a rare cancer of the immune system associated particularly with certain textured implants. In 2019, Allergan recalled its Biocell textured implants after they were linked to cases of BIA-ALCL, and regulators including the FDA have acted on it¹⁰. This is not the same as BII — it’s a defined, recognised cancer with an established (if rare) association, not a contested symptom cluster. Anyone with textured implants and concerns should discuss screening with their doctor.
What to do with all this
This isn’t medical advice, and decisions about implants are significant and personal — they belong with you and your doctors. But a few reasonable principles follow from the evidence:
- If you have implants and unexplained systemic symptoms, take them seriously — and get other causes properly investigated. Thyroid, autoimmune and other conditions share these symptoms and are treatable.
- Your symptoms being real doesn’t require a definitive diagnosis. The absence of a confirmatory test doesn’t mean nothing is happening.
- Removal helps many women, but not all, and it’s a serious decision to weigh with a qualified surgeon — not a guaranteed fix.
- Support your body’s general capacity to cope. Whatever the specific cause, the same things that help the body handle any burden — good nutrition, healthy detoxification and clearance pathways, managing overall load — are reasonable to attend to, independent of any claim about implants.
The short version
Breast implants shed compounds into the body over time, even intact — that much is documented. Like microplastics, this adds a burden most people seem to cope with and some don’t, depending on their individual capacity. BII isn’t a proven diagnosis and the cause isn’t established, but the symptoms are real, and the substantial majority of women who remove their implants report improvement. Taking that seriously, without overclaiming, is the honest and useful place to stand.
Frequently asked questions
Is breast implant illness real?
The symptoms are real and consistently reported across thousands of women. However, BII is not yet an established medical diagnosis, and a definitive causal link between implants and these symptoms hasn’t been proven. Both things are true at once — real symptoms, unproven cause.
Do breast implants leak even if they don’t rupture?
Yes. Implants release small amounts of material through “gel bleed” — diffusion through an intact shell — and silicone has been documented migrating to lymph nodes without the implant rupturing. Newer cohesive gels reduced this but didn’t eliminate it.
Why do only some women get symptoms?
Likely individual variation. People differ in how well they clear foreign compounds, how reactive their immune system is, and how much other burden they’re already carrying. The same exposure can affect one person and not another — similar to how not everyone with microplastics in their body develops problems.
Do symptoms improve after implant removal?
For many women, yes. Systematic reviews report symptom improvement in roughly 82–84% of patients where this was measured. This doesn’t prove implants caused the symptoms, and most studies are observational, but it’s a consistent and striking pattern.
What is BIA-ALCL?
Breast implant-associated anaplastic large cell lymphoma — a rare cancer of the immune system linked particularly to certain textured implants. It led to Allergan’s 2019 recall of its Biocell implants. It’s distinct from BII and is an established, if rare, association. Discuss screening with your doctor if you have textured implants.
Should I remove my implants?
That’s a significant, personal decision for you and a qualified surgeon. Removal helps many women but not all, and it isn’t guaranteed. It’s also important to have other causes of your symptoms investigated, since many overlap with treatable conditions.
References
- BII remains an unofficial medical diagnosis with no confirmatory test; its symptoms overlap with, but are not limited to, the proposed (and debated) ASIA syndrome. Bird & Niessen (2022), Scientific Reports, 12:21073; BII systematic review, PMC11013383.
- No single lab, scan or biopsy confirms BII, and no definitive causal link has been established; regulators describe it as patient-reported systemic symptoms with other causes to be ruled out first. Defining Breast Implant Illness meta-analysis (2025), PMC12088632.
- BII is a cluster of over 50 systemic symptoms attributed by patients to their implants, increasingly studied rather than dismissed. Bird & Niessen (2022).
- “Gel bleed” — diffusion of silicone through an intact implant shell — is an accepted phenomenon in the literature. Case Report: Migratory Silicone Particles, Frontiers in Global Women’s Health (2022), PMC9085291.
- Silicone migration to lymph nodes occurs without rupture; one series found silicone adenopathy in 91% of implant patients, with only ~49% of implants showing visible rupture. Errico et al., Gland Surgery; silicone migration case literature, PMC10852369.
- Highly cohesive silicone gels, introduced in the 1990s, substantially reduced gel bleed and migration compared with older implants but did not eliminate reports. Silicone migration case literature, PMC2810790.
- A 2024 systematic review (31 studies, ~39,505 patients) reported symptom improvement after explantation in ~83.5% of cases where reported. BII systematic review, PMC11013383.
- A 2025 meta-analysis (Ferreira) found ~81.9% of patients reported symptom improvement after explantation, averaging ~55% symptom reduction; most studies observational, limiting causal conclusions. Aesthetic Plastic Surgery (2025); Borsting evidence review.
- Across 36 studies and 10,519 patients, the most prevalent symptoms were joint complaints, fatigue/malaise, myalgia/weakness, cognitive dysfunction and undefined pain. Defining Breast Implant Illness meta-analysis (2025), PMC12088632.
- Allergan recalled its Biocell textured implants in 2019 following links to BIA-ALCL, a rare immune-system cancer; the FDA and other regulators have acted on it. FDA safety communications; BIA-ALCL literature.
